| Annual event rate per 100 | Annual event rate per 1000 | Absolute risk frequency per year |  | Annual event rate per 100 | Annual event rate per 1000 | Absolute risk frequency per year |
---|---|---|---|---|---|---|---|
All coxib vs All NSAID | Lumiracoxib vs NSAID | ||||||
PUB | Â | Â | Â | PUB | Â | Â | Â |
NSAID | 1.36 | 13.6 | 74 | NSAID | 1.21 | 12.1 | 83 |
All coxib | 0.56 | 5.6 | 179 | Lumiracoxib | 0.46 | 4.6 | 217 |
Difference | Â | 8.0 | 125 | Difference | Â | 7.5 | 133 |
APTC | Â | Â | Â | APTC | Â | Â | Â |
NSAID | 0.89 | 8.9 | 112 | NSAID | 0.82 | 8.2 | 122 |
All coxib | 0.97 | 9.7 | 103 | Lumiracoxib | 0.92 | 9.2 | 109 |
Difference | Â | -0.8 | -1250 | Difference | Â | -1.0 | -1000 |
Celecoxib vs NSAID | Valdecoxib vs NSAID | ||||||
PUB | Â | Â | Â | PUB | Â | Â | Â |
NSAID | 2.09 | 20.9 | 48 | NSAID | 1.95 | 19.5 | 51 |
Celecoxib | 0.93 | 9.3 | 108 | Valdecoxib | 0.68 | 6.8 | 147 |
Difference | Â | 11.6 | 86 | Difference | Â | 12.7 | 79 |
APTC | Â | Â | Â | APTC | Â | Â | Â |
NSAID | 1.20 | 12.0 | 83 | NSAID | 1.97 | 19.7 | 51 |
Celecoxib | 1.00 | 10 | 100 | Valdecoxib | 1.27 | 12.7 | 79 |
Difference | Â | 2.0 | 500 | Difference | Â | 7.0 | 143 |
Rofecoxib vs NSAID | Etoricoxib vs NSAID | ||||||
PUB | Â | Â | Â | PUB | Â | Â | Â |
NSAID | 0.90 | 9.0 | 111 | NSAID | 1.03 | 10.3 | 97 |
Rofecoxib | 0.33 | 3.3 | 303 | Etoricoxib | 0.47 | 4.7 | 213 |
Difference | Â | 5.7 | 175 | Difference | Â | 5.6 | 179 |
APTC | Â | Â | Â | APTC | Â | Â | Â |
NSAID | 0.87 | 8.7 | 115 | NSAID | 0.80 | 8.0 | 125 |
Rofecoxib | 1.19 | 11.9 | 84 | Etoricoxib | 0.91 | 9.1 | 110 |
Difference | Â | -3.2 | -313 | Difference | Â | -1.1 | -909 |